At NINGBO INNO PHARMCHEM CO.,LTD., we are dedicated to supplying essential chemical intermediates that fuel innovation in drug discovery. Today, we highlight the importance of 8-Benzyloxy-5-(2-bromoacetyl)-2-hydroxyquinoline, identified by its CAS number 100331-89-3. This compound is a cornerstone in the synthesis of phenylethanolamine derivatives, which are critical for the development of beta-2 adrenoreceptor agonists.

The journey of a drug from concept to market is complex, often beginning with the identification and synthesis of key intermediates. 8-Benzyloxy-5-(2-bromoacetyl)-2-hydroxyquinoline, with its specific chemical structure (C18H14BrNO3), offers chemists a versatile platform for creating molecules with targeted pharmacological effects. Its application in the synthesis of beta-2 adrenoreceptor agonists is particularly significant, as these drugs are vital for managing respiratory conditions. The reliable availability of this white solid intermediate is thus paramount for researchers in this field.

For drug discovery programs, sourcing reliable 8-Benzyloxy-5-(2-bromoacetyl)-2-hydroxyquinoline is a critical step. NINGBO INNO PHARMCHEM CO.,LTD. ensures that our supply meets the stringent purity and quality requirements of the pharmaceutical industry. We understand that the success of a synthesis pathway for phenylethanolamine derivatives depends heavily on the quality of the starting materials. Therefore, choosing us as your 8-Benzyloxy-5-(2-bromoacetyl)-2-hydroxyquinoline supplier guarantees a foundational element that supports your innovation.

The chemical properties of CAS 100331-89-3 are well-characterized, making it a predictable and effective reagent in various synthetic procedures. Its role extends beyond just being a precursor; it actively contributes to the structural integrity and potential efficacy of the final drug molecule. By providing this essential intermediate, NINGBO INNO PHARMCHEM CO.,LTD. aims to empower scientists and accelerate the discovery of new therapeutic solutions. Our commitment is to facilitate breakthroughs by ensuring access to high-quality chemical building blocks.

In the competitive landscape of drug discovery, having access to key intermediates like 8-Benzyloxy-5-(2-bromoacetyl)-2-hydroxyquinoline is a significant advantage. We encourage researchers and pharmaceutical companies to leverage our expertise and quality supply chain to expedite their development processes for beta-2 adrenoreceptor agonists and other vital medications.